| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |